Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_assertion type Assertion NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_head.
- NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_assertion description "[The presence of PDB in 28 (57%) individuals suggests that measuring serum alkaline phosphatase (ALP) activity may be a useful screen for IBMPFD in patients with myopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_provenance.
- NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_assertion evidence source_evidence_literature NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_provenance.
- NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_assertion SIO_000772 18260132 NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_provenance.
- NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_assertion wasDerivedFrom befree-2016 NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_provenance.
- NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_assertion wasGeneratedBy ECO_0000203 NP654443.RA1PJtE-E_nL_rm_1ZSaRGLkFn4WvsNfLPY45FCpfNvhE130_provenance.